XML 108 R29.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity (Tables)
3 Months Ended
Sep. 30, 2025
Stockholders' Equity  
Dividends declared and paid

The following table reflects the dividends paid per share within the respective three-month periods:

Fiscal Year

    

2026

    

2025

First fiscal quarter

$

0.120

$

0.120

Schedule of share repurchases

The following table summarizes all treasury stock purchases during the periods presented (in thousands, except per share amounts):

Three Months Ended

September 30, 

    

2025

2024

Number of treasury shares acquired

26

17

Average cost per share

$

5.16

$

5.15

Total cost of treasury shares acquired

$

132

$

88

Schedule of Market-based Award Valuation Assumptions

For performance-based awards granted during the three months ended September 30, 2025 and 2024, the assumptions used in the Monte Carlo simulation valuations were as follows:

Three Months Ended

September 30, 

    

2025

    

2024

Weighted average fair value of performance-based awards granted

$

4.36

$

3.90

Risk-free interest rate

3.55%

3.45%

Expected term in years

2.78

2.78

Expected volatility

40.6%

50.2%

Dividend yield

8.8%

8.4%

Schedule of restricted stock transactions

Unvested restricted stock awards as of September 30, 2025 consisted of the following:

Weighted

Number of

Average

Restricted

Grant-Date

Award Type

    

Shares

    

Fair Value

Time-vested awards

370,009

$

6.06

Performance-based awards

508,851

4.65

Unvested at September 30, 2025

878,860

$

5.24

Restricted Stock  
Stockholders' Equity  
Schedule of restricted stock transactions

The following table sets forth the restricted stock award transactions for the three months ended September 30, 2025:

Weighted

Weighted

Unamortized

Average

Number of

Average

Compensation

Remaining

Restricted

Grant-Date

Expense

Amortization

    

Shares

    

Fair Value

    

(In thousands)

    

Period (Years)

Unvested at June 30, 2025

670,285

$

5.58

$

2,196

1.6

Time-vested shares granted

93,353

5.47

Performance-based shares granted

186,709

4.36

Vested

(71,487)

6.41

Unvested at September 30, 2025

878,860

$

5.24

$

3,035

2.0

Contingent restricted stock grants  
Stockholders' Equity  
Schedule of restricted stock transactions

The following table sets forth contingent restricted stock unit transactions for the three months ended September 30, 2025:

Weighted

Unamortized

Average

Number of

Weighted Average

Compensation

Remaining

Restricted

Grant-Date

Expense

Amortization

 

    

Stock Units

    

Fair Value

    

(In thousands)

    

Period (Years)

Unvested at June 30, 2025

241,613

$

2.37

$

340

1.8

Unvested at September 30, 2025

241,613

$

2.37

$

288

1.6